Universitatsklinikum Carol Gustav Carus an der TU dDresden, Klinik umd Poliklinik fur Neurologie
Welcome,         Profile    Billing    Logout  
 0 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Falkenburger, Bjoern
ORION, NCT06122662: AMX0035 and Progressive Supranuclear Palsy

Active, not recruiting
2/3
110
Europe, US
AMX0035, Placebo
Amylyx Pharmaceuticals Inc.
Progressive Supranuclear Palsy, PSP, Neurodegenerative Diseases, Atypical Parkinsonism
04/26
11/29
LUMA, NCT05348785 / 2021-004849-20: A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80

Recruiting
2
640
Europe, Canada, Japan, US, RoW
BIIB122, DNL151, BIIB122-Matching Placebo
Biogen, Denali Therapeutics Inc.
Parkinson Disease
12/25
12/25
NCT06498349: Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseControl

Recruiting
N/A
60
Europe
bilateral high frequency deep brainstimulation of the subthalamic nucleus combined with best medical treatment, best medical treatment for management of impulse control in Parkinson´s disease, best medical treatment (BMT): Adjustment of the dopaminergic medication and non-dopaminergic therapy customized for each patient according to the latest published Consensus Group Recommendations
University of Kiel, Insel Gruppe AG, University Hospital Bern, Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC), Philipps University Marburg Medical Center, University Hospital Schleswig-Holstein, Campus Kiel, Czech Technical University in Prague, University of Pennsylvania
Parkinson Disease, Impulse Control Disorders
07/27
07/28
NCT06561919: STIMPulseControl Ancillary Speech Study

Recruiting
N/A
60
Europe
bilateral high frequency deep brain stimulation of the subthalamic neucleus combined with best medical treatment according to widely accepted expert consensus paper, best medical treatment for manangement of impulse control in Parkinson´s disease, best medical treatment for management of impulse control in Parkinson´s disease according to widely accepted expert consensus paper
Steffen Paschen, Czech Technical University in Prague, Insel Gruppe AG, University Hospital Bern, Philipps University Marburg Medical Center, University Hospital Schleswig-Holstein, Campus Kiel, Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
Parkinson Disease, Impulse Control Disorder
07/27
07/28
HDClarity, NCT02855476: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease

Recruiting
N/A
2500
Europe, Canada, US, RoW
University College, London, CHDI Foundation, Inc.
Huntington's Disease
05/25
05/25

Download Options